Even in States with Strong Stock Albuterol Laws, School Administrators Fear Liability

albuterol sulfate inhalation aerosol inhaler

Albuterol and epinephrine are both vital medications for the immediate treatment of life-threatening attacks of asthma and anaphylaxis. While many states permit central school systems to stock non-patient specific doses in case of emergencies, the schools and other entities have an unwarranted fear of liability. Read this article to better understand those fears and consider how the community can encourage entities to stock both of these medications.

Immunotherapy Skin Patch Shows Efficacy for Toddlers with Peanut Allergy

unshelled peanuts in a wooden bowl viewed from top

While we wait for Food and Drug Administration (FDA) approval for a skin patch immunotherapy for toddlers with peanut allergies, allergists and scientists have important new research showing how this patch could be used by individuals at risk for peanut allergy. In conversation with Helio, Dr. Matthew Greenhawt reports on "the incredible potential of epicutaneous therapy" for infants and young children. Broad based distribution of the patch is still several years away. In the meantime, read more about this research and the very promising possibilities here.

  • Home

Allergy Action Awards 2022

The Amazing Gary Ferrar, Allergy Action Awards 2022

Thank you to those who were able the festivities and support the organization. For those that that couldn't join us, enjoy the great fun  had by all with the  magician and mentalist Gary Ferrar. Gary amazed us all with feats of magic and "how did he do that?" We also learned our new favorite word is "labadalabada." Watch to the end to see why.

Articles for Advocacy

In an anaphylaxis emergency, epinephrine is THE physician recommended first line medication! No other treatment counteracts all the dangerous symptoms of anaphylaxis as quickly and effectively as epinephrine. But because epinephrine is administered with an auto injector (EAI) device which has a needle and requires an intermuscular injection, some doctors are reluctant to prescribe the device. Patients are also needlessly afraid to use one. Schools and other entities who are permitted to stock epinephrine are afraid to do so. It's a paradox that could cost someone's life. Our Epi Near You New York program addresses the issue of fear of epinephrine. Read more about how we can educate doctors to prescribe epinephrine sooner in the diagnostic process.

Epinephrine Autoinjectors Not Prescribed to Half of Adults With Severe Food Allergy

Allergy Food Epidemic chart

By Brandon May
November 11, 2022

LOUISVILLE, Kentucky — Nearly half of adults with food allergies have not been prescribed an epinephrine autoinjector (EAI) by their physician, according to survey results presented here at the American College of Allergy, Asthma, and Immunology (ACAAI) 2022 Annual Meeting.

Read the article here.

 

Research into ways to administer epinephrine without a needle has been under way for years. While the wait continues, it is exciting that neffy® the intranasal emergency epinephrine device being developed by ARS Pharmaceuticals has made it to the US FDA for review. Find the details about timing here.

FDA Accepts New Drug Application for Nasal Epinephrine Spray Treatment for Anaphylaxis

neffy® intranasan emergency epinephrine device
neffy® intranasal emergency epinephrine device
Dave Bloom

By Dave Bloom
2022/10/21

ARS Pharmaceuticals announced today that the US Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for their neffy® nasal epinephrine device for the emergency treatment of anaphylaxis in adults and children weighing 66 lbs and more.

Clinical trials confirmed a 2mg dose of epinephrine administered intranasally provided comparable pharmacokinetics as an administration from a traditional auto-injector.

Read the article here.

 

The information provided on this site is in no way intended to be a substitute for medical advice,
diagnosis, or treatment with a licensed physician.
The Allergy Advocacy Association is a 501(c)(3) non-profit, tax-exempt organization.
Copyright 2022 © Allergy Advocacy Association, Inc. All rights reserved.  Terms & Conditions